As the serum levels of MASP2 were higher in SLE patients and related to several clinical, laboratory characteristics as shown in the training cohort, it is possible that dysregulated serum MASP2 may be a disease marker for lupus. This evidence concerns the gene MASP2 and systemic lupus erythematosus.